Department of Nephrology and Transplantation, University Hospitals Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2WB, UK.
Research Informatics, Research Development and Innovation, University Hospitals Birmingham, Queen Elizabeth Hospital, Birmingham, UK.
BMC Nephrol. 2022 Aug 4;23(1):273. doi: 10.1186/s12882-022-02902-8.
Waterlow scoring was introduced in the 1980s as a nursing tool to risk stratify for development of decubitus ulcers (pressure sores) and is commonly used in UK hospitals. Recent interest has focussed on its value as a pre-op surrogate marker for adverse surgical outcomes, but utility after kidney transplantation has never been explored.
In this single-centre observational study, data was extracted from hospital informatics systems for all kidney allograft recipients transplanted between 1 January 2007 and 30 June 2020. Waterlow scores were categorised as per national standards; 0-9 (low risk), 10-14 (at risk), 15-19 (high risk) and ≥ 20 (very high risk). Multiple imputation was used to replace missing data with substituted values. Primary outcomes of interest were post-operative length of stay, emergency re-admission within 90-days and mortality analysed by linear, logistic or Cox regression models respectively.
Data was available for 2,041 kidney transplant patients, with baseline demographics significantly different across Waterlow categories. As a continuous variable, the median Waterlow score across the study cohort was 10 (interquartile range 8-13). As a categorical variable, Waterlow scores pre-operatively were classified as low risk (n = 557), at risk (n = 543), high risk (n = 120), very high risk (n = 27) and a large proportion of missing data (n = 794). Median length of stay in days varied significantly with pre-op Waterlow category scores, progressively getting longer with increasing severity of Waterlow category. However, no difference was observed in risk for emergency readmission within 90-days of surgery with severity of Waterlow category. Patients with 'very high risk' Waterlow scores had increased risk for mortality at 41.9% versus high risk (23.7%), at risk (17.4%) and low risk (13.4%). In adjusted analyses, 'very high risk' Waterlow group (as a categorical variable) or Waterlow score (as a continuous variable) had an independent association with increase length of stay after transplant surgery only. No association was observed between any Waterlow risk group/score with emergency 90-day readmission rates or post-transplant mortality after adjustment.
Pre-operative Waterlow scoring is a poor surrogate marker to identify kidney transplant patients at risk of emergency readmission or death and should not be utilised outside its intended use.
Waterlow 评分于 20 世纪 80 年代作为一种护理工具引入,用于对压疮(压力性溃疡)的发生风险进行分层,在英国医院中广泛应用。最近,人们对其作为手术不良结局的术前替代标志物的价值产生了兴趣,但从未探讨过其在肾移植后的效用。
在这项单中心观察性研究中,从医院信息系统中提取了 2007 年 1 月 1 日至 2020 年 6 月 30 日期间接受肾移植的所有肾移植受者的数据。Waterlow 评分按照国家标准进行分类:0-9(低危)、10-14(高危)、15-19(高危)和≥20(极高危)。采用多重插补法用替代值替换缺失数据。通过线性、逻辑或 Cox 回归模型分别分析术后住院时间、90 天内急诊再入院和死亡率等主要结局。
研究共纳入 2041 例肾移植患者,Waterlow 分类的基线特征在各亚组间存在显著差异。在整个研究队列中,Waterlow 评分的中位数为 10(四分位距 8-13)。作为分类变量,术前 Waterlow 评分分为低危(n=557)、高危(n=543)、高危(n=120)、极高危(n=27)和大量缺失数据(n=794)。术后住院时间在各 Waterlow 分类组间差异显著,随 Waterlow 分类严重程度的增加而逐渐延长。然而,在手术 90 天内急诊再入院风险方面,Waterlow 分类严重程度无差异。Waterlow 评分极高危的患者死亡率为 41.9%,显著高于高危(23.7%)、高危(17.4%)和低危(13.4%)。在调整分析中,Waterlow 评分极高危组(作为分类变量)或 Waterlow 评分(作为连续变量)与移植术后住院时间延长有独立相关性。调整后,Waterlow 风险组/评分与术后 90 天内急诊再入院率或移植后死亡率之间均无相关性。
术前 Waterlow 评分不能作为识别肾移植患者急诊再入院或死亡风险的替代标志物,不建议超出其预期用途使用。